CTMX (CytomX Therapeutics, Inc.) Stock Market Reviews

crown

search

Read and share opinions on CTMX (CytomX Therapeutics, Inc.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock marke

CTMX

CytomX Therapeutics, Inc.

clarify Biotechnology

bookmark Healthcare

public United States

Sell Neutral Buy

Latest News

CytomX Therapeutics to Present at the Jefferies London Healthcare Conference
Nov 13, 2025
Downgrade: Here's How Analysts See CytomX Therapeutics, Inc. (NASDAQ:CTMX) Performing In The Near Term
Nov 13, 2025
CytomX Therapeutics (CTMX): Assessing Valuation After Phase 1 CX-801 Data Preview at SITC Annual Meeting
Nov 9, 2025
CytomX Therapeutics Inc (CTMX) Q3 2025 Earnings Call Highlights: Navigating Revenue Decline ...
Nov 7, 2025
CytomX Therapeutics (CTMX) Reports Q3 Loss, Lags Revenue Estimates
Nov 7, 2025
CytomX Therapeutics: Q3 Earnings Snapshot
Nov 6, 2025
CytomX Therapeutics Announces Third Quarter 2025 Financial Results and Provides Business Update
Nov 6, 2025
CytomX Therapeutics to Present CX-801 Phase 1 Monotherapy Biomarker Data at the Society for Immunotherapy of Cancer (SITC) Annual Meeting
Nov 4, 2025
Oppenheimer Remains a Buy on CytomX Therapeutics (CTMX), Sets a $7 PT
Oct 31, 2025
CytomX Therapeutics to Report Third Quarter 2025 Financial Results on November 6, 2025
Oct 30, 2025
CytomX Therapeutics Appoints Rachael Lester as Chief Business Officer
Oct 20, 2025
Declining Stock and Solid Fundamentals: Is The Market Wrong About CytomX Therapeutics, Inc. (NASDAQ:CTMX)?
Aug 30, 2025
CytomX Therapeutics to Present at Upcoming September Investor Conferences
Aug 28, 2025
CytomX Therapeutics Provides Update on CX-2051 Phase 1 Study
Aug 13, 2025

Reviews